Thyroxine replacement modifies changes in deiodinase and thyroid hormone transporter expression induced by

Kelen Carneiro Oliveira1, Roberto Laureano-Melo2, Rodrigo Rodrigues da Conceição3

  • 1Laboratório de Endocrinologia Molecular e Translacional- LEMT, Divisão de Endocrinologia, Departamento de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, Vila Clementino, São Paulo, SP, 04039032, Brazil.

Hormones (Athens, Greece)
|September 30, 2020
PubMed
Abstract

Insights

Treating subclinical hypothyroidism (SCH) with thyroxine (T4) normalized gene expression of deiodinases and thyroid hormone transporters in rats. Early T4 treatment may prevent clinical symptoms of hypothyroidism.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Animal Models

Background:

  • Subclinical hypothyroidism (SCH) treatment remains controversial.
  • Thyroid hormone (TH) deiodinases and transporters play crucial roles in TH metabolism and action.
  • Understanding gene expression changes in SCH is vital for determining optimal treatment strategies.

Purpose of the Study:

  • To investigate the effects of thyroxine (T4) replacement on deiodinase and TH transporter gene expression in a rat model of surgically induced SCH.
  • To evaluate tissue-specific changes in gene expression in response to SCH and T4 treatment.

Main Methods:

  • Subclinical hypothyroidism (SCH) was induced in rats via hemithyroid electrocauterization.
  • Thyroxine (T4) replacement therapy was administered to a subset of SCH rats.
  • Serum hormone levels and gene expression (deiodinases, TH transporters) were analyzed in various tissues.

Main Results:

  • SCH rats exhibited altered expression of deiodinases (Dio1, Dio2, Dio3) and TH transporters (Mct10, Mct8, Crym) in a tissue-specific manner.
  • T4 replacement therapy normalized TSH levels and reverted most altered gene expressions to sham levels.
  • Significant changes were observed in the pituitary, hippocampus, kidney, liver, and hypothalamus.

Conclusions:

  • Thyroxine (T4) replacement effectively modulates gene expression of deiodinases and TH transporters in SCH.
  • These findings support considering T4 treatment for SCH before overt clinical symptoms manifest.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.7K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.6K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
4.8K
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
58.0K